SAMSUNG PHARM. Co., LTD. (KOSE:A001360) acquired 3.1% stake in Enerzent Co., Ltd. (KOSDAQ:A041590) for KRW 3 billion on January 14, 2019. SAMSUNG PHARM. Co., LTD acquired 1.38 million shares at KRW 2,165 per share.

SAMSUNG PHARM. Co., LTD. (KOSE:A001360) completed the acquisition of 3.1% stake in Enerzent Co., Ltd. (KOSDAQ:A041590)on January 14, 2019.